This is where medications like semaglutide may provide meaningful benefit
A recent phase 2 trial explored semaglutide doses up to 16 mg weekly in patients with type 2 diabetes and overweight
Wegovy has been clinically tested for safety and efficacy when following the FDA-approved dose titration
Shapiro, MD, a board-certified general surgery specialist and the Medical Director of the Comprehensive Breast Center at Wellington Regional Medical Center in Wellington, Florida, explains that semaglutide injections can cause a burning sensation at the injection site
However, these organizations recommend that healthcare providers monitor any changes in menstrual cycles or vaginal bleeding patterns when starting new medications, especially in women who are perimenopausal or postmenopausal
A: Yes, Semaglutide is actually FDA-approved for treating type 2 diabetes in addition to weight loss